Overland Park, KS3 Active Studies

Ankylosing Spondylitis Clinical Trials in Overland Park, KS

Find 3 actively recruiting ankylosing spondylitis clinical trials in Overland Park, KS. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
1,968
Enrolling

Recruiting Ankylosing Spondylitis Studies in Overland Park

About Ankylosing Spondylitis Clinical Trials in Overland Park

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 3 ankylosing spondylitis clinical trials recruiting participants in Overland Park, KS. These studies are seeking a combined 1,968 participants. Research is being sponsored by University of Kansas Medical Center, Pfizer, Antidote Therapeutics, Inc. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Overland Park — FAQ

Are there ankylosing spondylitis clinical trials in Overland Park?

Yes, there are 3 ankylosing spondylitis clinical trials currently recruiting in Overland Park, KS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Overland Park?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Overland Park research site will contact you about next steps.

Are clinical trials in Overland Park free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Overland Park studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 3 active trials in Overland Park are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated July 21, 2026 from ClinicalTrials.gov